Stockholders Equity (Details) $ / shares in Units, $ in Thousands |
1 Months Ended | 3 Months Ended | 12 Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2020 |
Mar. 31, 2021
$ / shares
shares
|
Mar. 30, 2021 |
Mar. 31, 2021
USD ($)
$ / shares
shares
|
Dec. 31, 2020
shares
|
Dec. 31, 2019
$ / shares
|
Mar. 10, 2021
shares
|
Jan. 01, 2021
shares
|
Jan. 01, 2020
shares
|
Nov. 30, 2017
shares
|
May 31, 2017
$ / shares
shares
|
|
| Stockholders Equity (Details) [Line Items] | |||||||||||
| Market sales agreement, description | pursuant to a registration statement on Form S-3 declared effective by the Securities and Exchange Commission on December 11, 2020, the Company entered into an Open Market Sales Agreement (“ATM Agreement”) with Jefferies LLC. (“Jefferies”), which provides that, upon the terms and subject to the conditions and limitations in the ATM Agreement, the Company may elect, from time to time, to offer and sell shares of Common Stock with an aggregate offering price of up to $50,000, with Jefferies acting as sales agent. During the three months ended March 31, 2021, the Company sold 601,674 shares of Common Stock under the ATM Agreement, at an average price of $7.20 per share, raising aggregate net proceeds of approximately $4,334, after deducting an aggregate commission of $134. | ||||||||||
| Number of shares available to grant | 1,846,554 | 1,846,554 | |||||||||
| Vesting period | 4 years | ||||||||||
| Fair value at the grant date (in Dollars) | $ | $ 5,138 | ||||||||||
| Shares of issued warrants | 362,444 | ||||||||||
| Shares, Issued | 362,383 | ||||||||||
| Warrants were fully vested and exercisable | 236,552 | 118,277 | |||||||||
| Warrants cancelled | 236,553 | ||||||||||
| New Incentive Plan [Member] | |||||||||||
| Stockholders Equity (Details) [Line Items] | |||||||||||
| Grant options (in Dollars per share) | $ / shares | $ 1,000 | ||||||||||
| Equity incentive plan, description | The aggregate number of shares of Common Stock that may be delivered pursuant to the 2019 Plan will automatically increase on January 1 of each year, commencing on January 1, 2020 and ending on (and including) January 1, 2029, in an amount equal to four percent (4%) of the total number of shares of Common Stock outstanding on December 31 of the preceding calendar year (“Evergreen Amount”) | ||||||||||
| Stock Options [Member] | |||||||||||
| Stockholders Equity (Details) [Line Items] | |||||||||||
| Grant approved | 985,530 | ||||||||||
| Exercise price (in Dollars per share) | $ / shares | $ 7.02 | $ 7.02 | |||||||||
| Yeda [Member] | |||||||||||
| Stockholders Equity (Details) [Line Items] | |||||||||||
| Shares of issued warrants | 7,615 | ||||||||||
| Scientific Founders [Member] | |||||||||||
| Stockholders Equity (Details) [Line Items] | |||||||||||
| Shares of issued warrants | 2,974 | ||||||||||
| 2019 Plan [Member] | |||||||||||
| Stockholders Equity (Details) [Line Items] | |||||||||||
| Number of shares available to grant | 930,813 | 914,741 | |||||||||
| Employees consideration, description | the Board of Directors approved the grant of 985,530 options to 94 employees, including five senior officers, one consultant, and six directors under the 2019 Plan, without consideration. | ||||||||||
| License Agreement [Member] | |||||||||||
| Stockholders Equity (Details) [Line Items] | |||||||||||
| Warrants to purchase common stock | 591,382 | ||||||||||
| Shares Issued, Price Per Share (in Dollars per share) | $ / shares | $ 0.0001 | ||||||||||